Dr. Fabienne Zeegers
Trainer
Fabienne is a consultant and a trainer in the health sector. She obtained her PhD in analytical chemistry at the University of Leuven in 1992. Fabienne spent almost 30 years in the Pharmaceutical industry within the Research and Development organisation. She spent her first years as Data Management project leader and Clinical Trial Manager. In 2004, with the entry into force of the EU Clinical Trial Directive (CTD), she created and headed an unit in charge of centrally prepare the Clinical Trial Application dossiers for all countries around the global (except the US). In that endeavour, she had been deeply involved through EU Trade association in the development and the implementation of the EU Clinical Trial Regulation (CTR). In 2016, Fabienne moved into the Global Regulatory Sciences organisation as Global Regulatory Policy Lead where she bridged regulatory policies and development strategy in the areas such as Real World Evidence (RWE), Complex Clinical Trials and Digital Health. Fabienne was also an EU Oncology Regulatory Strategy liaison.
Fabienne has always been passionate about transfer knowledge and people development.
Reasons to attend Clinical Trial Regulations are known to be complex on the one hand, on the other ...
Reasons to attend This course on the EU Clinical Trial Regulation (CTR) and the Notification of ser...
Reasons to attend Our course on ICH guideline E8 (R1) General Considerations for Clinical Studies...
Reasons to attend This course is developed for senior level people in charge of organisations who n...
Reasons to attend If you are a clinical research professional, investigator, monitor or other staff...
Reasons to attend The European Clinical Trial Regulation 536/2014, of April 2014, is to become the ...
Reasons to attend The aim of this course is to provide an overview of the EU CTR 536/2014 (CTR) and...